Clincosm LogoSign in Get a demo

hereditary angioedema (hae)

Showing 1 - 25 of 32
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hereditary Angioedema (HAE) Trial (CSL312)

Not yet recruiting
  • Hereditary Angioedema (HAE)
  • CSL312
  • (no location specified)
Apr 17, 2023

Teenagers and Hereditary Angioedema Type I or Type II Who Use

Completed
  • Hereditary Angioedema (HAE)
    • Graz, Austria
    • +19 more
    Jan 12, 2023

    Teenagers and Non-histaminergic Angioedema With Normal C1

    Not yet recruiting
    • Hereditary Angioedema (HAE)
    • Angioedema
    • No Intervention
    • (no location specified)
    Jan 5, 2023

    Hereditary Angioedema (HAE) Trial in Worldwide (Lanadelumab)

    Available
    • Hereditary Angioedema (HAE)
    • Angioedema
    • Lanadelumab 150 mg
    • Lanadelumab 300 mg
    • Scottsdale, Arizona
    • +19 more
    Sep 16, 2022

    Icatibant in Pediatric Participants With Hereditary Angioedema

    Not yet recruiting
    • Hereditary Angioedema (HAE)
    • (no location specified)
    Aug 19, 2022

    Hereditary Angioedema Who Currently Receive Icatibant at Home

    Not yet recruiting
    • Hereditary Angioedema (HAE)
    • No Intervention
    • London, United Kingdom
      Sciensus
    Aug 4, 2022

    Lanadelumab in Teenagers and Hereditary Angioedema (HAE)

    Not yet recruiting
    • Hereditary Angioedema (HAE)
    • No Intervention
    • London, England, United Kingdom
      Barts Health NHS Trust
    Jul 20, 2022

    Hereditary Angioedema (HAE) Trial in China (Lanadelumab)

    Recruiting
    • Hereditary Angioedema (HAE)
    • Guangzhou, Guangdong, China
    • +3 more
    Jul 13, 2022

    Lanadelumab in Participants With Hereditary Angioedema

    Recruiting
    • Hereditary Angioedema (HAE)
    • Tokyo, T, Japan
      Takeda selected site
    Jun 22, 2022

    Lanadelumab in Persons With Hereditary Angioedema in Poland

    Recruiting
    • Hereditary Angioedema (HAE)
      • Wrocław, Dolnośląskie, Poland
      • +13 more
      Jun 15, 2022

      FIRAZYR General Drug Use-Results Survey (Japan)

      Recruiting
      • Hereditary Angioedema (HAE)
      • Nagoya, Aichi, Japan
      • +17 more
      Feb 23, 2022

      Lanadelumab in Persons With Hereditary Angioedema Type I or II

      Recruiting
      • Hereditary Angioedema (HAE)
        • Wien, Austria
        • +19 more
        Dec 13, 2021

        Lanadelumab in Persons With Hereditary Angioedema Type I or II

        Active, not recruiting
        • Hereditary Angioedema (HAE)
          • Birmingham, Alabama
          • +28 more
          Dec 17, 2021

          Hereditary Angioedema (HAE) Trial in Japan (Lanadelumab)

          Completed
          • Hereditary Angioedema (HAE)
          • Toyohashi-shi, Aichi-Ken, Japan
          • +11 more
          Sep 23, 2021

          Hereditary Angioedema (HAE) Trial in Wheaton (ecallantide, Phosphate Buffer Saline (PBS),)

          Completed
          Has Results
          • Hereditary Angioedema (HAE)
          • Wheaton, Maryland
            Institute for Asthma and Allergy
          Jun 3, 2021

          Hereditary Angioedema (HAE) Trial in Canada, Jordan, United States (ecallantide)

          Completed
          Has Results
          • Hereditary Angioedema (HAE)
          • Scottsdale, Arizona
          • +40 more
          May 14, 2021

          Hereditary Angioedema (HAE) Trial in Canada, Jordan, United States (ecallantide, Phosphate Buffer Saline (PBS), pH 7.0)

          Completed
          Has Results
          • Hereditary Angioedema (HAE)
          • Scottsdale, Arizona
          • +44 more
          May 14, 2021

          Hereditary Angioedema (HAE) Trial in Glendale (Icatibant (30 mg))

          Completed
          Has Results
          • Hereditary Angioedema (HAE)
          • Icatibant (30 mg)
          • Glendale, California
            PAREXEL
          May 13, 2021

          Hereditary Angioedema (HAE) Trial in Worldwide (CINRYZE with rHuPH20)

          Completed
          Has Results
          • Hereditary Angioedema (HAE)
          • CINRYZE with rHuPH20
          • Birmingham, Alabama
          • +22 more
          May 11, 2021

          Hereditary Angioedema (HAE) Trial in Miami (Recombinant human C1 esterase inhibitor, Placebo, SHP623)

          Completed
          Has Results
          • Hereditary Angioedema (HAE)
          • Recombinant human C1 esterase inhibitor
          • +2 more
          • Miami, Florida
            Clinical Pharmacology of Miami
          May 13, 2021

          Hereditary Angioedema (HAE) Trial in Worldwide (CINRYZE 500, CINRYZE 1000)

          Completed
          Has Results
          • Hereditary Angioedema (HAE)
          • CINRYZE 500
          • CINRYZE 1000
          • Colorado Springs, Colorado
          • +7 more
          May 11, 2021

          Hereditary Angioedema (HAE) Trial in Germany, Hungary, United States (CINRYZE)

          Completed
          Has Results
          • Hereditary Angioedema (HAE)
          • CINRYZE
          • Colorado Springs, Colorado
          • +10 more
          May 11, 2021

          Hereditary Angioedema (HAE) Trial in Japan (Icatibant)

          Completed
          Has Results
          • Hereditary Angioedema (HAE)
          • Fukushima, Japan
          • +7 more
          May 13, 2021

          Hereditary Angioedema (HAE) Trial in Worldwide (DX-2930 - 300mg/2wk, DX-2930 - 300mg/4wk, DX-2930 - 150mg/4wk)

          Completed
          Has Results
          • Hereditary Angioedema (HAE)
          • DX-2930 - 300mg/2wk
          • +3 more
          • Birmingham, Alabama
          • +40 more
          May 13, 2021

          Hereditary Angioedema (HAE) Trial in Japan (CINRYZE 500 U, CINRYZE 1000 U)

          Completed
          Has Results
          • Hereditary Angioedema (HAE)
          • CINRYZE 500 U
          • CINRYZE 1000 U
          • Toyohashi, Aiti, Japan
          • +9 more
          May 13, 2021